Program Description
In 2025, several new medications were approved by the Food and Drug Administration (FDA). Pharmacists, as integral members of the health care team, must stay informed about these new approvals to provide optimal patient care. This activity will focus on the identification and review of selected new medications approved by the FDA in 2025. Understanding the indications along with a review of key characteristics of these medications, including their dosing regimens, administration methods, and safety profiles, is crucial for pharmacists to recommend appropriate therapies and ensure patients receive the most effective treatments. This activity will equip pharmacists and pharmacy technicians with valuable insights into the latest approved medications, so they may appropriately implement them into patient care to improve health outcomes. Staying current with these innovations is vital for pharmacists to maintain their role as knowledgeable and trusted health care providers.
Target Audience: Ambulatory Care Pharmacist, Community Pharmacist, Health System Pharmacist, Pharmacy Technician, Specialty PharmacistType of Activity: Knowledge
Release date: January
27, 2026
Expiration date: January
27, 2027
Learner
level: Foundational
Time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of
this activity, participants will be able to:
- Identify the clinical indications and common adverse effects of the new drugs approved by the US Food and Drug Administration in 2025
- Point out important aspects of newly approved drugs, including dosing, administration, and safety profiles to properly assess, counsel, and monitor patients on therapy